Dyadic International Company Top Insiders

DYAI Stock  USD 0.86  0.03  2.98%   
Dyadic International employs about 6 people. A leadership review of Dyadic International matters because management quality often shapes how effectively strategy is translated into revenue growth, margins, and cash generation. That matters because management quality often influences how well a company responds when business conditions become less favorable.
Mark Emalfarb  Chairman
Founder, CEO and President Director and Chairman of Nominating Committee

Management Team Effectiveness

The company has return on total asset (ROA) of -36.14 % which indicates that it has lost $36.14 on every $100 of assets. This falls well below what is typical for the industry. Similarly, it shows a return on stockholder's equity (ROE) of -422.64 %, which implies that it generated negative returns to current shareholders.
As of now, Common Stock Shares Outstanding is anticipated to decline to approximately 31 M. In addition to that, The current year's Net Loss is projected to rise to approximately -8.3 M.

Stock Institutional Investors

Dyadic International has 11.39% institutional ownership and 25.17% insider stake. Annual revenue is about 3.5 Million. This mix shapes how the stock trades around earnings. The business currently sits in the Health Care sector and the Pharmaceuticals, Biotechnology & Life Sciences industry. Short interest and volume patterns add useful context given the ownership split.
Shares
Hightower Advisors, Llc2025-12-31
79.5 K
Northern Trust Corp2025-09-30
67.9 K
Ae Wealth Management Llc2025-12-31
53.8 K
Alphacore Capital Llc2025-12-31
50.8 K
Lpl Financial Corp2025-12-31
44.9 K
State Street Corp2025-09-30
42.5 K
Appleseed Capital2025-12-31
41.7 K
Xtx Topco Ltd2025-12-31
36.3 K
Inlet Private Wealth, Llc2025-12-31
30 K
Apis Capital Advisors, Llc2025-12-31
1.5 M
Vanguard Group Inc2025-12-31
915 K
At 32.75 Million, Dyadic International sits in smaller-cap territory where institutional context matters most alongside valuation and volatility readings. The business currently sits in the Healthcare sector and the Biotechnology industry. Shares outstanding are near 36.2 M. Comparing institutional flows with insider activity and short interest builds a fuller picture for a smaller-cap like Dyadic International.

Insider Trading Activities

Tracking Dyadic International's insider filings adds context. Executives often respond to business conditions well before market sentiment shifts. Current market capitalization is about 32.75 Million. These records work best as context, not as standalone buy-or-sell signals.
 
Rawson Ping Wang over a month ago
Acquisition by Rawson Ping Wang of 20776 shares of Dyadic International subject to Rule 16 b-3
 
Mark Emalfarb over two months ago
Acquisition by Mark Emalfarb of 126000 shares of Dyadic International at 0.94 subject to Rule 16 b-3
 
Tarnok Michael P. over three months ago
Disposition of 23585 shares by Tarnok Michael P. of Dyadic International subject to Rule 16 b-3
 
Kaye Jack over six months ago
Disposition of 22500 shares by Kaye Jack of Dyadic International at 1.33 subject to Rule 16 b-3
 
Bose Arindam over six months ago
Disposition of 10776 shares by Bose Arindam of Dyadic International subject to Rule 16 b-3
 
Joseph Hazelton over six months ago
Acquisition by Joseph Hazelton of 25000 shares of Dyadic International at 1.04 subject to Rule 16 b-3
 
Kaye Jack over a year ago
Disposition of 22500 shares by Kaye Jack of Dyadic International at 1.33 subject to Rule 16 b-3
 
Lucy Patrick K. over a year ago
Acquisition by Lucy Patrick K. of 23585 shares of Dyadic International subject to Rule 16 b-3
 
Kaye Jack over a year ago
Acquisition by Kaye Jack of 67500 shares of Dyadic International at 1.74 subject to Rule 16 b-3
 
Herbst Seth over a year ago
Acquisition by Herbst Seth of 6250 shares of Dyadic International at 0.97 subject to Rule 16 b-3
 
Mark Emalfarb over a year ago
Acquisition by Mark Emalfarb of 172000 shares of Dyadic International at 1.74 subject to Rule 16 b-3
 
Tarnok Michael P. over a year ago
Disposition of 18750 shares by Tarnok Michael P. of Dyadic International at 0.97 subject to Rule 16 b-3

Outstanding Bonds

Outstanding bonds linked to Dyadic International can tell investors a great deal about how the company finances itself beyond common equity markets. Used together with earnings and cash-flow analysis, the bond stack can reveal whether leverage is a manageable tool or a developing constraint.
Dyadic International has a large amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Dyadic International has approximately 11% of its outstanding shares held by institutional investors, 25% by insiders, and 63% in public hands.
 
Shares in Circulation  
 First Issued
2003-03-31
 Previous Quarter
30.1 M
 Current Value
34.5 M
 Average Shares Outstanding
27.8 M
 Quarterly Volatility
7.4 M
Macro event markers
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

Holders Distribution

Institutional investors in Dyadic International typically operate with more research capacity, technology, and trading scale than retail holders, which is why their activity can materially affect price behavior. This matters because getting in early on a sponsorship cycle may help, but getting caught near a large-holder exit can have the opposite effect.

Market Cap and Value

Workforce Comparison

Dyadic International is rated below average for number of employees among direct rivals. The total workforce of Health Care industry is currently estimated at about 357. Dyadic International claims roughly 6.0 in number of employees contributing just under 2% to equities under Health Care sector.

Profit Margins

The company has Profit Margin (PM) of -1.35 %, which suggests that the company is operating at a loss at the net level. This falls well below what is typical for the industry. Similarly, it shows Operating Margin (OM) of -1.77 %, which entails that for every $100 of revenue, the company lost $1.77 at the operating level.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.620.59
Sufficiently Up
Pretty Stable

Insider Trading History

Dyadic International's insider log provides a timeline of management conviction alongside earnings and guidance changes. Investors focus on trades outside normal pay timelines, as those are more likely to reflect genuine conviction.

Notable Stakeholders

A Dyadic International stakeholder is any individual or group with an interest in the outcome of the business, which is why stakeholder analysis can reveal who may influence strategy and oversight. The practical value is that investors can see where interests align, where they conflict, and how that tension could influence execution.
Mark EmalfarbFounder, CEO and President Director and Chairman of Nominating CommitteeProfile
Ronen TcheletVP of Bus. Devel. for EuropeProfile
Joseph HazeltonChief OfficerProfile
Doug BAExecutive DevelopmentProfile
Ana RodriguezSecretary BoardProfile

Management Information & Data Sources

Dyadic International is a micro-cap company across Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care. Insider transaction activity tracks recent buying and selling by executives and directors. Clusters of insider purchases can signal internal confidence, though context and timing matter. CEO is Mark Emalfarb with 6 employees and 5 reported executives.

Inputs for Dyadic International come from periodic company reporting and market reference feeds and are mapped into a consistent reporting framework. Some fields can appear with publication lag. Insider and management fields are mapped from published filings and company disclosures.

This content is curated and reviewed by:

Ellen Johnson - Member of Macroaxis Editorial Board
Last reviewed on March 24th, 2026

Workforce Efficiency and Productivity

Manpower analysis for Dyadic International matters because revenue per employee and profit per employee can reveal shifts in productivity and operating discipline. This is most informative when investors want to connect operating scale with efficiency rather than reviewing headcount in isolation.

Dyadic International Manpower Efficiency

Return on Dyadic International Manpower

Revenue Per Employee582.6K
Revenue Per Executive699.1K
Net Loss Per Employee968.2K
Net Loss Per Executive1.2M
Working Capital Per Employee1.2M
Working Capital Per Executive1.5M

Popular Tools for Dyadic Stock analysis

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device